Thomas L Wadzinski1, Katherine Geromini, Judy McKinley Brewer, Ruby Bansal, Nadia Abdelouahab, Marie-France Langlois, Larissa Takser, R Thomas Zoeller. 1. Department of Biology (T.L.W., K.G., J.M.B., R.B., R.T.Z.), University of Massachusetts Amherst, Amherst, Massachusetts 01003; Department of Pediatrics (T.L.W.), Baystate Medical Center, Springfield, Massachusetts 01199; and Department of Pediatrics (N.A., L.T.), Faculty of Medicine, and Department of Medicine (M.-F.L.), Endocrinology Service, Faculty of Medicine, University of Sherbrooke, Sherbrooke, Qéubec, Canada J1H SN4.
Abstract
CONTEXT: Thyroid hormone (TH) is essential for normal development; therefore, disruption of TH action by a number of industrial chemicals is critical to identify. Several chemicals including polychlorinated biphenyls are metabolized by the dioxin-inducible enzyme CYP1A1; some of their metabolites can interact with the TH receptor. In animals, this mechanism is reflected by a strong correlation between the expression of CYP1A1 mRNA and TH-regulated mRNAs. If this mechanism occurs in humans, we expect that CYP1A1 expression will be positively correlated with the expression of genes regulated by TH. OBJECTIVE: The objective of the study was to test the hypothesis that CYP1A1 mRNA expression is correlated with TH-regulated mRNAs in human placenta. METHODS: One hundred sixty-four placental samples from pregnancies with no thyroid disease were obtained from the GESTE study (Sherbrooke, Québec, Canada). Maternal and cord blood TH levels were measured at birth. The mRNA levels of CYP1A1 and placental TH receptor targets [placental lactogen (PL) and GH-V] were quantitated by quantitative PCR. RESULTS: CYP1A1 mRNA abundance varied 5-fold across 132 placental samples that had detectable CYP1A1 mRNA. CYP1A1 mRNA was positively correlated with PL (r = 0.64; P < .0001) and GH-V (P < .0001, r = 0.62) mRNA. PL and GH-V mRNA were correlated with each other (r = 0.95; P < .0001), suggesting a common activator. The mRNAs not regulated by TH were not correlated with CYP1A1 expression. CONCLUSIONS: CYP1A1 mRNA expression is strongly associated with the expression of TH-regulated target gene mRNAs in human placenta, consistent with the endocrine-disrupting action of metabolites produced by CYP1A1.
CONTEXT: Thyroid hormone (TH) is essential for normal development; therefore, disruption of TH action by a number of industrial chemicals is critical to identify. Several chemicals including polychlorinated biphenyls are metabolized by the dioxin-inducible enzyme CYP1A1; some of their metabolites can interact with the TH receptor. In animals, this mechanism is reflected by a strong correlation between the expression of CYP1A1 mRNA and TH-regulated mRNAs. If this mechanism occurs in humans, we expect that CYP1A1 expression will be positively correlated with the expression of genes regulated by TH. OBJECTIVE: The objective of the study was to test the hypothesis that CYP1A1 mRNA expression is correlated with TH-regulated mRNAs in human placenta. METHODS: One hundred sixty-four placental samples from pregnancies with no thyroid disease were obtained from the GESTE study (Sherbrooke, Québec, Canada). Maternal and cord blood TH levels were measured at birth. The mRNA levels of CYP1A1 and placental TH receptor targets [placental lactogen (PL) and GH-V] were quantitated by quantitative PCR. RESULTS:CYP1A1 mRNA abundance varied 5-fold across 132 placental samples that had detectable CYP1A1 mRNA. CYP1A1 mRNA was positively correlated with PL (r = 0.64; P < .0001) and GH-V (P < .0001, r = 0.62) mRNA. PL and GH-V mRNA were correlated with each other (r = 0.95; P < .0001), suggesting a common activator. The mRNAs not regulated by TH were not correlated with CYP1A1 expression. CONCLUSIONS:CYP1A1 mRNA expression is strongly associated with the expression of TH-regulated target gene mRNAs in human placenta, consistent with the endocrine-disrupting action of metabolites produced by CYP1A1.
Authors: K J Barber; J A Franklyn; C J McCabe; F L Khanim; J N Bulmer; G S J Whitley; M D Kilby Journal: J Clin Endocrinol Metab Date: 2004-12-14 Impact factor: 5.958
Authors: Jaime Freitas; Patricia Cano; Christina Craig-Veit; Michael L Goodson; J David Furlow; Albertinka J Murk Journal: Toxicol In Vitro Date: 2010-08-21 Impact factor: 3.500
Authors: P Huuskonen; M Storvik; M Reinisalo; P Honkakoski; J Rysä; J Hakkola; M Pasanen Journal: Clin Pharmacol Ther Date: 2007-10-27 Impact factor: 6.875
Authors: Kelly J Gauger; Stefanie Giera; David S Sharlin; Ruby Bansal; Eric Iannacone; R Thomas Zoeller Journal: Environ Health Perspect Date: 2007-11 Impact factor: 9.031
Authors: Somiranjan Ghosh; Partha S Mitra; Christopher A Loffredo; Tomas Trnovec; Lubica Murinova; Eva Sovcikova; Svetlana Ghimbovschi; Shizhu Zang; Eric P Hoffman; Sisir K Dutta Journal: Environ Res Date: 2015-02-27 Impact factor: 6.498
Authors: A C Gore; V A Chappell; S E Fenton; J A Flaws; A Nadal; G S Prins; J Toppari; R T Zoeller Journal: Endocr Rev Date: 2015-11-06 Impact factor: 19.871
Authors: Bram G Janssen; Wilfried Gyselaers; Hyang-Min Byun; Harry A Roels; Ann Cuypers; Andrea A Baccarelli; Tim S Nawrot Journal: J Transl Med Date: 2017-01-04 Impact factor: 5.531
Authors: Jennifer J Adibi; Alexander J Layden; Rahel L Birru; Alexandra Miragaia; Xiaoshuang Xun; Megan C Smith; Qing Yin; Marisa E Millenson; Thomas G O'Connor; Emily S Barrett; Nathaniel W Snyder; Shyamal Peddada; Rod T Mitchell Journal: Hum Reprod Update Date: 2021-06-22 Impact factor: 15.610